You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dornase alfa

Showing 1 - 25 of 1,388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Trauma, Respiratory Distress Syndrome, Adult Trial in Strasbourg (Dornase Alfa Inhalant Solution [Pulmozyme], Placebos)

Recruiting
  • Multiple Trauma
  • Respiratory Distress Syndrome, Adult
  • Dornase Alfa Inhalant Solution [Pulmozyme]
  • Placebos
  • Strasbourg, France
    University Hospital, Strasbourg, france
Jul 7, 2022

Ischemic Stroke Trial (Administration of dornase alfa)

Not yet recruiting
  • Ischemic Stroke
  • Administration of dornase alfa
  • (no location specified)
Apr 21, 2022

COVID19, Hypoxia Trial in London (Dornase Alfa Inhalation Solution [Pulmozyme])

Completed
  • COVID19
  • Hypoxia
  • Dornase Alfa Inhalation Solution [Pulmozyme]
  • London, United Kingdom
    University College London Hospital
Nov 8, 2021

COVID-19, Acute Respiratory Distress Syndrome Trial in Paris (Dornase Alfa Inhalation Solution [Pulmozyme], standard procedure)

Terminated
  • COVID-19
  • Acute Respiratory Distress Syndrome
  • Dornase Alfa Inhalation Solution [Pulmozyme]
  • standard procedure
  • Paris, France
    Hôpital Fondation A. de Rotschhild
Dec 20, 2021

COVID-19 Pneumonia Trial (Dornase Alfa, Saline)

Not yet recruiting
  • COVID-19 Pneumonia
  • (no location specified)
Dec 1, 2021

Ischemic Stroke, Inflammatory Response Trial in Munich (Dornase Alfa, Isotonic Saline Solution)

Not yet recruiting
  • Ischemic Stroke
  • Inflammatory Response
  • Dornase Alfa
  • Isotonic Saline Solution
  • Munich, Bavaria, Germany
    Institute for Stroke and Dementia Research, Ludwig Maximilian Un
Jun 1, 2023

SARS-CoV 2, ARDS Trial in Columbia (Dornase Alfa Inhalation Solution)

Completed
Has Results
  • SARS-CoV 2
  • ARDS
  • Dornase Alfa Inhalation Solution
  • Columbia, Missouri
    University of Missouri Hospital and Clinics
Apr 12, 2021

COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml

Recruiting
  • COVID-19 Severe Respiratory Failure
  • Alexandroupolis, Evros, Greece
    University Hospital of Alexandroupolis
Mar 11, 2022

COVID Trial in Boston, Weymouth (Pulmozyme, Placebo)

Recruiting
  • COVID
  • Boston, Massachusetts
  • +2 more
Dec 7, 2021

Loculated or Non-draining Malignant Pleural Effusions Trial in Philadelphia (Combination TISSUE PLASMINOGEN ACTIVATOR (TPA) AND

Recruiting
  • Loculated or Non-draining Malignant Pleural Effusions
  • Combination TISSUE PLASMINOGEN ACTIVATOR (TPA) AND DORNASE ALFA (DNASE)
  • Philadelphia, Pennsylvania
    Eastern Regional Medical Center
Feb 10, 2021

Dornase Alfa Administered to Patients With COVID-19 (DACOVID)

Completed
  • COVID-19
  • Mechanical Ventilation
  • Dornase Alfa
  • Manhasset, New York
    Feinstein Insitute for Medical Research at Northwell Health
Nov 12, 2020

COVID-19, Coronavirus Disease 2019 Trial in Moscow (Tigerase® and best available care, Best available care)

Completed
  • COVID-19
  • Coronavirus Disease 2019
  • Tigerase® and best available care
  • Best available care
  • Moscow, Russian Federation
  • +5 more
Oct 13, 2020

Cystic Fibrosis, Fibrosis Trial in Russian Federation (Tigerase®, Pulmozyme®)

Completed
  • Cystic Fibrosis
  • Fibrosis
  • Tigerase®
  • Pulmozyme®
  • Barnaul, Altai Region, Russian Federation
  • +13 more
Jul 8, 2020

COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +18 more
Jul 19, 2021

Sjogren's Syndrome, Cough Trial in Farmington (Dornase alfa, Saline)

Withdrawn
  • Sjogren's Syndrome
  • Cough
  • Farmington, Connecticut
    University of CT Health Center
Jan 13, 2020

Lung Transplant Infection, Lower Respiratory Tract Infection Trial in Melbourne (Dornase Alfa, Isotonic Saline.)

Completed
Has Results
  • Lung Transplant Infection
  • Lower Respiratory Tract Infection
  • Dornase Alfa
  • Isotonic Saline.
  • Melbourne, Victoria, Australia
    The Alfred
Jul 22, 2019

Healthy Subjects Trial in Groningen (JHL1922, dornase alfa)

Completed
  • Healthy Subjects
  • JHL1922
  • dornase alfa
  • Groningen, Netherlands
    JHL Biotech Investigational Site
Jan 5, 2020

Qualitative Understanding of Experiences With the SIMPLIFY Trial

Recruiting
  • Cystic Fibrosis
  • Drug Withdrawal
  • Qualitative Interview
  • Baltimore, Maryland
  • +1 more
Mar 26, 2022

Pleural Empyema Trial in Canada (TPA (Tissue Plasminogen Activator), DNase, Placebo)

Completed
Has Results
  • Pleural Empyema
  • TPA (Tissue Plasminogen Activator)
  • +2 more
  • Calgary, Alberta, Canada
  • +5 more
Apr 6, 2020

Non-cystic Fibrosis Bronchiectasis Trial in United States (ARINA-1, Placebo)

Not yet recruiting
  • Non-cystic Fibrosis Bronchiectasis
  • Birmingham, Alabama
  • +8 more
Aug 10, 2022

Cystic Fibrosis, Mucociliary Clearance Defect Trial in Iowa City, Columbia (Symptom driven performance of airway clearance,

Not yet recruiting
  • Cystic Fibrosis
  • Mucociliary Clearance Defect
  • Symptom driven performance of airway clearance
  • Continuous daily performance of airway clearance
  • Columbia, Missouri
    University of Missouri Hospital and Clinics
Dec 12, 2022

Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)

Not yet recruiting
  • Hypophosphatasia
  • Hartford, Connecticut
  • +29 more
Oct 6, 2023

Fabry Disease Under Enzyme Replacement Therapy With

Recruiting
  • Fabry Disease
  • Berlin, Germany
  • +7 more
Oct 17, 2023

Hypophosphatasia Trial in Würzburg (Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg)

Recruiting
  • Hypophosphatasia
  • Ilofotase Alfa, 0.8 mg/kg
  • Ilofotase Alfa, 3.2 mg/kg
  • Würzburg, Germany
    Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KL
May 26, 2023

Outcomes in Hospitalised Patients Treated With Ondexxya

Not yet recruiting
  • Hemorrhage
  • Andexanet alfa
  • (no location specified)
Jun 12, 2023